nuclear cataracts_Cryga<1Neu>/Cryga<+>

http://metadb.riken.jp/0010254I101C3HCryga1NeuCrygaCrygaCryga1Neu

nuclear cataracts_Cryga<1Neu>/Cryga<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• crystallin, gamma A
  http://metadb.riken.jp/db/mgi_rdf/MGI:88521

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cryga<1Neu>/Cryga<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cryga<+>|Cryga<1Neu>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 101 * C3H

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• nuclear cataracts
  http://purl.obolibrary.org/obo/MP_0010254

文献

http://purl.org/net/cito/citesAsAuthority

• J. Favor, A comparison of the dominant cataract and recessive specific-locus mutation rates induced by treatment of male mice with ethylnitrosourea., Mutation research, 1983, 110
  http://rdf.ncbi.nlm.nih.gov/pubmed/6877261
• J. Favor, Characterization of dominant cataract mutations in mice: penetrance, fertility and homozygous viability of mutations recovered after 250 mg/kg ethylnitrosourea paternal treatment., Genetical research, 1984, 44
  http://rdf.ncbi.nlm.nih.gov/pubmed/6510713